Found 5 matching trials
A Dose Escalation Study of the Safety and Pharmacokinetics of GSK1363089 (Formerly XL880) Administered Orally Daily to Subjects With Solid Tumors
PHASE1This clinical study is being conducted at two sites to determine the optimu...
Location
Multiple Locations
A Dose Escalation Study of the Safety and Pharmacokinetics of GSK1363089 (Formerly XL880) Administered Orally to Subjects With Solid Tumors
PHASE1This clinical study is being conducted at two sites to determine the optimu...
Location
Multiple Locations
A Phase II Study of GSK1363089 (Formerly XL880) for Papillary Renal-Cell Carcinoma (PRC)
PHASE2This clinical study is being conducted at multiple sites to determine the b...
Location
GSK Investigational Site
Study of GSK1363089 in Metastatic Gastric Cancer
PHASE2This clinical study is being conducted at multiple sites to determine the b...
Location
GSK Investigational Site
Phase 2 Study of GSK1363089 (Formerly XL880) in Adults With Squamous Cell Cancer of the Head and Neck
PHASE2This study is being conducted to determine the best confirmed response rate...
Location
GSK Investigational Site